Show simple item record

dc.contributor.authorYahya, S
dc.contributor.authorBhatt, Lubna
dc.contributor.authorKing, M
dc.contributor.authorPirrie, S
dc.contributor.authorWyatt, R
dc.contributor.authorAnwar, M
dc.contributor.authorEl-Modir, A
dc.contributor.authorFernando, I
dc.date.accessioned2015-11-23T12:13:13Zen
dc.date.available2015-11-23T12:13:13Zen
dc.date.issued2015-10en
dc.identifier.citationSurvival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding. 2015, 35 (10):5567-74 Anticancer Resen
dc.identifier.issn1791-7530en
dc.identifier.pmid26408727en
dc.identifier.urihttp://hdl.handle.net/10541/582536en
dc.description.abstractWe report on outcomes and significant grade 3-4 late toxicities between January 1999 and October 2006 following introduction of multi-phase treatment and effect of shielding in treatment of cervical cancer with concurrent chemoradiation.
dc.language.isoenen
dc.rightsArchived with thanks to Anticancer researchen
dc.titleSurvival and toxicity following chemoradiation for carcinoma of the cervix - impact of multiple-phase treatment and shielding.en
dc.typeArticleen
dc.contributor.departmentHall Edwards Radiotherapy Research group, Cancer Centre, Queen Elizabeth Hospital, Birmingham, U.K.en
dc.identifier.journalAnticancer Researchen
html.description.abstractWe report on outcomes and significant grade 3-4 late toxicities between January 1999 and October 2006 following introduction of multi-phase treatment and effect of shielding in treatment of cervical cancer with concurrent chemoradiation.


This item appears in the following Collection(s)

Show simple item record